We have data on 52 companies that use SnpEff. The companies using SnpEff are most often found in United States and in the Higher Education industry. SnpEff is most often used by companies with >10000 employees and >1000M dollars in revenue. Our data for SnpEff usage goes back as far as 1 years and 11 months.
|Cancer Genetics Inc||cancergenetics.com||United States||10M-50M||200-500|
|JACKSON LABORATORY||jax.org||United States||200M-1000M||1000-5000|
|NEW YORK GENOME CENTER INC||nygenome.org||United States||100M-200M||200-500|
|UNIVERSITY OF PITTSBURGH||pitt.edu||United States||10M-50M||>10000|
|University of Delaware||udel.edu||United States||>1000M||>10000|
We use the best indexing techniques combined with advanced data science to monitor the market share of over 12,500 technology products, including Healthcare. By scanning billions of public documents, we are able to collect deep insights on every company, with over 100 data fields per company at an average. In the Healthcare category, SnpEff has a market share of about 0.1%. Other major and competing products in this category include:
SnpEff is an open source tool that annotates variants and predicts their effects on genes by using an interval forest approach. This program takes pre-determined variants listed in a data file that contains the nucleotide change and its position and predicts if the variants are deleterious.
Looking at SnpEff customers by industry, we find that Higher Education (28%), Hospital & Health Care (24%) and Biotechnology (7%) are the largest segments.
62% of SnpEff customers are in United States.